StreetInsider.com News Articles

IDEXX Laboratories to Release 2026 Second Quarter Financial Results

Wed, 01 Jul 2026 16:00:00 -0400

WESTBROOK, Maine--(BUSINESS WIRE)-- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2026 second quarter financial results for Tuesday, August 4, 2026, before the market opens. The Company will conduct an analyst conference call beginning at 8:30 a.m. ET on that day.

Individuals can access a live webcast of the conference call, transcript of prepared remarks, and the Q2 2026 Earnings Snapshot through a link on the IDEXX website, www.idexx.com/investors. An archived edition of the webcast will be available after 1:00

IDEXX Laboratories to Release 2026 Second Quarter Financial Results

Wed, 01 Jul 2026 16:00:00 -0400

IDEXX Laboratories to Release 2026 Second Quarter Financial Results

Wed, 01 Jul 2026 16:00:00 -0400

IDEXX Laboratories to Release 2026 Second Quarter Financial Results

Wed, 01 Jul 2026 16:00:00 -0400

Form 4 IDEXX LABORATORIES INC For: Jun 01 Filed by: FENNELL GEORGE

Tue, 02 Jun 2026 17:00:00 -0400

si-local-file:///var/storage/secattach/20260602/26592853.html

Form 4 IDEXX LABORATORIES INC For: Jun 01 Filed by: FENNELL GEORGE

Tue, 02 Jun 2026 17:00:00 -0400

si-local-file:///var/storage/secattach/20260602/26592853.html

Form SD IDEXX LABORATORIES INC

Mon, 01 Jun 2026 16:00:00 -0400

si-local-file:///var/storage/secattach/20260601/26583282.html

Form SD IDEXX LABORATORIES INC

Mon, 01 Jun 2026 16:00:00 -0400

si-local-file:///var/storage/secattach/20260601/26583282.html

IDEXX adds tapeworm detection to Fecal Dx testing platform

Tue, 26 May 2026 07:01:19 -0400

IDEXX Laboratories Inc. (NASDAQ: IDXX) announced the expansion of its Fecal Dx antigen testing platform to include detection of taeniid tapeworm, including Taenia and Echinococcus species.

The company stated that Fecal Dx antigen testing can detect up to twice as many intestinal parasite infections earlier than fecal flotation alone. Since launching in 2012, more than 50 million Fecal Dx antigen tests have been conducted worldwide.

This marks the third menu expansion in four years for the platform. The addition brings the total number of detected intestinal parasite groups to seven, including hookworm, roundworm, whipworm, flea tapeworm, taeniid tapeworm, Cystoisospora and Giardia in

IDEXX Expands Fecal Dx Antigen Testing Platform with Taeniid Tapeworm Detection

Tue, 26 May 2026 07:00:00 -0400

Third menu expansion in four years broadens intestinal parasite detection in routine care

WESTBROOK, Maine--(BUSINESS WIRE)-- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced the expansion of its Fecal Dx™ antigen testing platform with taeniid tapeworm, including Taenia and Echinococcus species. Proven to detect up to twice as many intestinal parasite infections earlier than fecal flotation alone,1 Fecal Dx antigen testing delivers broader parasite detection in a single test for both wellness and sick-pet care.